Mechanisms and Models of SPTAN1 Epileptic Encephalopathy
SPTAN1癫痫性脑病的机制和模型
基本信息
- 批准号:10053733
- 负责人:
- 金额:$ 19.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-01 至 2021-11-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcuteAdhesionsAnimalsAxonBindingBrainC-terminalCell CommunicationCell Culture TechniquesCell modelCellsClustered Regularly Interspaced Short Palindromic RepeatsComplexCytoskeletonDNADNA Sequence AlterationDataDevelopmentDevelopment PlansDevelopmental Delay DisordersDiseaseDisease modelDisinhibitionDoctor of MedicineDoctor of PhilosophyDominant-Negative MutationDyskinetic syndromeElectrophysiology (science)ElectroporationElementsEmbryoEpilepsyEpileptogenesisExcitatory SynapseFibroblastsFoundationsFunctional disorderFundingFutureGenesGeneticGenetic studyGoalsGrantHeterodimerizationHumanImpaired cognitionIn VitroInfantInfantile spasmsInhibitory SynapseIntellectual functioning disabilityKnowledgeLaboratoriesLeadLightLinkManuscriptsMechanical StressMediatingMedicineMembraneMethodsModelingMolecularMusMutateMutationNatureNeurologistNeurologyNeuronsNeurosciencesPaperPathogenicityPatientsPeriodicityPhysiciansPlayProcessProsencephalonProteinsPublishingRattusReporterResearchRoleScientistSeizuresSideSliceSpectrinStructureStudy modelsSystemTestingTherapeutic StudiesTrainingTraining ActivityViralViral VectorWorkWritingbasebeta Spectrincareercareer developmentchildhood epilepsyde novo mutationdrug use screeningearly childhoodepileptic encephalopathiesexcitatory neurongenetic manipulationgenome editinghippocampal pyramidal neuronhuman modelin uteroin vitro Modelin vivoin vivo Modelinduced pluripotent stem cellinfancyinhibitory neuroninnovationinsightmigrationmutantnervous system disorderneurodevelopmentneuron developmentnoveloverexpressionpostsynapticskillsstem cell biologystem cell modelsuccesssynaptogenesistool
项目摘要
Abstract/Project Summary
Applicant: Dr. Wang holds M.D. and Ph.D. degrees, and has completed specialized training in both neurology
and epilepsy. During his Ph.D. work, he published 9 manuscripts including three first-author papers in
Neuroscience and one second-author paper in Nature Medicine. During his neurology training, he conducted a
genetic study on familial paroxysmal kinesigenic dyskinesia and co-authored one paper (under review).
Research Plan: Defining how genetic mutations that cause infantile epileptic encephalopthies (IEEs) disrupt
neurodevelopment should provide conceptual insights broadly relevant to understanding brain development
and epilepsy mechanisms. Using CRISPR genome editing methods, in utero electroporation (IUE) and human
induced pluripotent stem cell (iPSC) cultures, I propose to study the function of SPTAN1, a recently identified
gene (encoding alpha II-spectrin) mutated in patients presenting with IEE. My preliminary data show that
SPTAN1 regulates critical aspects of neuronal development, including axonal initial segment (AIS) formation,
process outgrowth and clustering of postsynaptic proteins. My central hypotheses are that SPTAN1 plays
critical roles in neurodevelopment through regulating neuronal migration, process outgrowth and synapse
formation, and that disinhibition of excitatory neurons leads to seizures in SPTAN1 IEE. I propose two specific
aims to test my hypotheses: 1) To determine how deleting Sptan1 or overexpressing mutant SPTAN1 in
cortical pyramidal neurons alters brain development and network excitability; and 2) To establish how
mutations in SPTAN1 influence excitatory and inhibitory cortical neuron development and excitability
using patient-derived iPSCs. This innovative proposal combines a rat IUE in vivo model (Aim 1) and an in
vitro model with patient-derived neurons (Aim 2). These models will be invaluable tools to study brain
development, and will also serve as an entry point for future drug screening using patient-derived neurons.
Immediate and long-term career goals: My career goal is to become an independent physician-scientist
focusing on brain development and genetic epilepsies. My long-term goal is to understand how genetic
mutations alter neurodevelopment and ultimately lead to seizures and intellectual disability. My short-term goal
is to obtain knowledge (e.g., stem cell biology and electrophysiology) and skills (e.g., iPSC cultures, viral-
based gene manipulation) in neuroscience to fill the gaps of my previous training in order to augment my
chances of success as an independently funded neuroscientist. The key elements of this research career
development plan are 5 key training goals. They are stem cell biology, electrophysiology principles, viral vector
based genetic manipulation, grant writing and laboratory management skills.
摘要/项目摘要
申请人:王博士拥有医学博士学位。和博士学位,并完成了神经病学和神经病学的专业培训,
和癫痫。在他的PhD他发表了9篇手稿,其中包括三篇第一作者论文,
神经科学和一个第二作者在自然医学论文。在他的神经病学培训期间,他进行了一次
家族性阵发性运动诱发性运动障碍的遗传学研究,并与人合著了一篇论文(正在审查中)。
研究计划:确定导致婴儿癫痫性脑病(IEE)的基因突变如何破坏
神经发育应该提供与理解大脑发育广泛相关的概念性见解
和癫痫机制。使用CRISPR基因组编辑方法,在子宫内电穿孔(IUE)和人
诱导多能干细胞(iPSC)培养,我建议研究SPTAN 1的功能,SPTAN 1是最近发现的
基因(编码α II-血影蛋白)在IEE患者中发生突变。初步数据显示
SPTAN 1调节神经元发育的关键方面,包括轴突起始段(AIS)形成,
突触后蛋白质的生长和聚集。我的主要假设是SPTAN 1扮演着
通过调节神经元迁移、突起生长和突触在神经发育中起关键作用
在SPTAN 1 IEE中,兴奋性神经元的去抑制导致癫痫发作。我建议两个具体的
目的是验证我的假设:1)为了确定缺失Sptan 1或过表达突变体SPTAN 1在
皮质锥体神经元改变大脑发育和网络兴奋性;和2)为了建立如何
SPTAN 1突变影响兴奋性和抑制性皮质神经元发育和兴奋性
使用患者来源的iPSC。这种创新的建议结合了大鼠IUE体内模型(Aim 1)和在体外的IUE模型(Aim 1)。
体外模型与患者来源的神经元(目的2)。这些模型将是研究大脑的宝贵工具
开发,也将作为未来使用患者来源的神经元进行药物筛选的切入点。
近期和长期的职业目标:我的职业目标是成为一名独立的医生-科学家
专注于大脑发育和遗传性癫痫我的长期目标是了解基因
突变会改变神经发育,最终导致癫痫发作和智力残疾。我的短期目标
是为了获得知识(例如,干细胞生物学和电生理学)和技能(例如,iPSC培养物,病毒-
基于基因操作)在神经科学中,以填补我以前的训练空白,以增加我的
作为一个独立资助的神经科学家,成功的机会。这个研究生涯的关键要素
发展计划是5个主要的培训目标。它们是干细胞生物学、电生理学原理、病毒载体
基于遗传操作,赠款写作和实验室管理技能。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Somatic Depdc5 deletion recapitulates electroclinical features of human focal cortical dysplasia type IIA.
- DOI:10.1002/ana.25272
- 发表时间:2018-07
- 期刊:
- 影响因子:11.2
- 作者:Hu S;Knowlton RC;Watson BO;Glanowska KM;Murphy GG;Parent JM;Wang Y
- 通讯作者:Wang Y
Early and Bi-hemispheric seizure onset in a rat glioblastoma Multiforme model.
- DOI:10.1016/j.neulet.2021.136351
- 发表时间:2022-01-01
- 期刊:
- 影响因子:2.5
- 作者:Hu S;Kao HY;Yang T;Wang Y
- 通讯作者:Wang Y
Widespread labeling and genomic editing of the fetal central nervous system by in utero CRISPR AAV9-PHP.eB administration.
- DOI:10.1242/dev.195586
- 发表时间:2021-01-20
- 期刊:
- 影响因子:0
- 作者:Hu S;Yang T;Wang Y
- 通讯作者:Wang Y
Leaky Blood-Brain Barrier: A Double Whammy for the Brain.
血脑屏障渗漏:对大脑的双重打击。
- DOI:10.1177/1535759720917920
- 发表时间:2020
- 期刊:
- 影响因子:3.6
- 作者:Wang,Yu
- 通讯作者:Wang,Yu
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yu Wang其他文献
Yu Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yu Wang', 18)}}的其他基金
Cortical development and pathogenesis in DEPDC5-related epilepsies
DEPDC5 相关癫痫的皮质发育和发病机制
- 批准号:
10624357 - 财政年份:2019
- 资助金额:
$ 19.01万 - 项目类别:
Cortical development and pathogenesis in DEPDC5-related epilepsies
DEPDC5 相关癫痫的皮质发育和发病机制
- 批准号:
10409774 - 财政年份:2019
- 资助金额:
$ 19.01万 - 项目类别:
Cortical development and pathogenesis in DEPDC5-related epilepsies
DEPDC5 相关癫痫的皮质发育和发病机制
- 批准号:
10164883 - 财政年份:2019
- 资助金额:
$ 19.01万 - 项目类别:
Cortical development and pathogenesis in DEPDC5-related epilepsies
DEPDC5 相关癫痫的皮质发育和发病机制
- 批准号:
10016841 - 财政年份:2019
- 资助金额:
$ 19.01万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 19.01万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 19.01万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 19.01万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 19.01万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 19.01万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 19.01万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 19.01万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 19.01万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 19.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 19.01万 - 项目类别:
Standard Grant